Research Tracker›Biomarker Atlas›Long COVID›5-Hydroxykynurenine

5-Hydroxykynurenine in Long COVID

In Long COVID (PASC, Post-Acute Sequelae of COVID-19), published studies report higher levels of 5-Hydroxykynurenine, also described as Kynurenine pathway, than in healthy controls. The cited literature links this alteration to neurotoxic metabolite pathway. This entry summarises Saito et al. 2024. Group-level associations like this do not translate into an individual diagnostic cut-off.

↑ ElevatedMetabolic

Summary

Direction in Long COVID↑ Elevated — higher than in the comparison group
CategoryMetabolic
Also described asKynurenine pathway
Compared againstHC (healthy controls)
Associated symptomsNeurotoxic metabolite pathway
Test typeBlood test (serum / plasma / whole blood)
SourceSaito et al. 2024 — doi:10.3389/fimmu.2024.1341843
Condition atlasLong COVID Biomarker Atlas

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Serum Biomarker Analysis (1 registered trials use a matching outcome measure).

Clinical trials using 5-Hydroxykynurenine as an outcome

Related Metabolic markers in Long COVID

Full list: Long COVID Biomarker Atlas.

Frequently asked questions

Is 5-Hydroxykynurenine high or low in Long COVID?

Elevated. Studies summarised in the OSMF atlas report higher 5-Hydroxykynurenine in Long COVID than in healthy controls. Source: Saito et al. 2024.

What symptoms is 5-Hydroxykynurenine associated with in Long COVID?

The cited literature associates this marker with Neurotoxic metabolite pathway. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures 5-Hydroxykynurenine?

It is measured as a blood test (serum / plasma / whole blood). Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal 5-Hydroxykynurenine result diagnostic of Long COVID?

No. No single biomarker is diagnostic of Long COVID. 5-Hydroxykynurenine findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). 5-Hydroxykynurenine in Long COVID: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/long-covid/5-hydroxykynurenine.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from long-covid.json · Browse: Long COVID atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.